Jinwon Life Sciences, Top Search Ranking... Stock Price -2.88%
As of 10:32 AM on the 22nd, Jinwon Life Sciences is trading at 10,100 KRW, down 2.88% from the previous day. This represents a 27.34% decline compared to April 23. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.
Today, foreigners are tentatively recorded as net buyers of 15,018 shares. Over the past five days, individual investors have net purchased 105,676 shares, while foreigners and institutions have net sold 111,823 shares and net purchased 3,566 shares, respectively.
On May 21, Jinwon Life Sciences made headlines in the market with the news "US Inovio COVID-19 vaccine induces antibody formation in mice."
[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
